Alex Drijver

Biography

Alex Drijver has been the CEO of ThalesNano Inc. since July 2016 and the CEO of Cominnex Inc. since April 2015 after 7 years as CEO of ChemAxon, a leader in providing chemical software development platforms for the biotechnology and pharmaceutical industries. He was a founder and former CEO of ThalesNano where he had a number of operating roles at the company between 2002 and 2007. Earlier he was Chief Financial Officer at ComGenex Inc. and Vice President of ABN AMRO Bank in London, and then Budapest. Before joining ABN AMRO, he worked in different financial and investment related positions in London for 10 years. He is the holder of the R&D 100's Award and the Hungarian Venture Capital Association’s SME of the Year Award and served on the Board of the Pistoia Alliance (a cross industry alliance to bring down barriers to open innovation in pharmaceutical research IT) from 2010 to 2015.

Research Interest

biotechnology and pharmaceuticals, nanotechnology, chemicals, software.